Eravacycline pharmacokinetics in a critically ill patient receiving venovenous extracorporeal membrane oxygenation and continuous venovenous haemodialysis

J Antimicrob Chemother. 2021 Sep 15;76(10):2738-2739. doi: 10.1093/jac/dkab238.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Continuous Renal Replacement Therapy*
  • Critical Illness
  • Extracorporeal Membrane Oxygenation*
  • Humans
  • Tetracyclines

Substances

  • Tetracyclines
  • eravacycline